The Alzheimer’s Research UK (ARUK) Drug Discovery Alliance, an initiative aiming to translate findings from academic research into potential treatments rapidly, is a comprised of three Drug Discovery Institutes in Cambridge, Oxford and University College London. In this interview, John Skidmore, BA, DPhil, of the ARUK Cambridge Drug Discovery Institute, Cambridge, UK, discusses how this ambitious partnership is different to typical institutes, with a promising outlook on the discovery of novel treatments. This video was recorded at the ARUK Conference 2018, held in London, UK.
